|
Market Closed -
NYSE
16:00:02 2026-11-18 EST
|
5-day change | 1st Jan Change | ||
| 5.500 USD | -1.96% |
|
-8.94% | -55.50% |
| 11-16 | Emergent BioSolutions, Asimov Enter Cell Line Development Partnership Targeting Ebola | MT |
| 11-04 | Emergent BioSolutions Gets Anthrax Vaccine Contract Modification Up to $22.3M | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- EBS Stock
- Charts Emergent BioSolutions Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
















